A 41-year-old female patient presented to the neurology clinic with the complaint of headache. Cranial computed tomography (CT) image revealed a contrast-enhanced mass on the right basal ganglia plane, consistent with a metastatic lesion. To detect the primary origin, a fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) scan was performed. A hypermetabolic mass in the right inferior lobe of the lung and another hypermetabolic mass measuring 3.5x4.7 cm and indicating a high FDG uptake with a high maximum standardized uptake value (SUVmax) of 74.6 and spreading through the left atrium via the pulmonary veins were detected (Fig. A) . Transesophageal echocardiography revealed a mobile mass measuring 3.3x2.5 cm attached to the lateral wall of the left atrium (Fig. B-F) . CT-guided transthoracic needle biopsy of the lesion was performed to obtain a histopathological diagnosis. The histopathological evaluation showed pleomorphic tumor cells with a large nucleus and a high level of mitotic activity (Fig. G ). An immunohistochemical evaluation revealed diffuse immunohistopathological staining in the tumor cells for S100 protein, melanoma antigen, and human melanoma black-45, consistent with malignant melanoma (MM) (Fig. H) . Based on the histopathological diagnosis of MM, the patient was sent for consultation with the dermatology clinic. She had no previous medical history of MM, atypical nevus, or nevus excision. A detailed dermatological examination was performed, which revealed no primary cutaneous lesion or atypical nevus. The patient was transferred to the oncology department with a diagnosis of metastatic MM with unknown primary origin; however, during follow-up, she died due to multi-organ failure. 
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